Elixie

Nano-Tech Cannabinoid products

Health Tech & Life Sciences
Active
Seed Caesarea, Israel Founded 2019
Last updated 2026-06-18
Total raised
$2.0M
Last: 2021-01
Stage
Seed
Founded
2019
Headcount
6
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

Elixie is a clinical-stage biotech company enhancing cannabinoids for symptomatic relief of neurological disorders based on NANOLIX, a patented clinically proven Self-nano emulsifying drug delivery system (SNEDDS).

By encapsulating validated APIs in in-human-proven NANOLIX and targeting orphan diseases, Elixie will register pharmaceuticals in a relatively short route to market and with minimal risks.

Funding history · 1 round · $2.0M total

2021-01
$2.0M

Q&A

What is Elixie's primary focus?
Elixie is a clinical-stage biotech company focused on enhancing cannabinoids for symptomatic relief of neurological disorders, utilizing its patented NANOLIX drug delivery system.
When was Elixie founded?
Elixie was founded in October 2019.
What is Elixie's total funding to date?
Elixie has raised a total of $2,000,000 USD.
When did Elixie complete its last funding round?
Elixie completed its last funding round in January 2021, raising $2,000,000 USD.
What is Elixie's current employee count?
Elixie currently has 1-10 employees.
Who is the co-founder and CEO of Elixie?
Yaron Shoob is the Co-founder & CEO of Elixie.
What is Elixie's primary sector classification?
Elixie's primary sector is Health Tech & Life Sciences.

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug Delivery
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B2CB2B

Highlights

1 PatentsVerified

Tags

chronic-painnanotechnologymultiple-sclerosisdrug-deliverycannabispharma-companiesmedical-technologiespharmaceuticalsepilepsychronic-diseasemedical-cannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteelixie.com
LinkedInlinkedin.com/company/64527214

Identifiers & details

Former namesAset Dev Ltd
Founded2019-10
Employees (exact)6
OfficesGiv'atayim

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainelixie.com

Certificate / subdomain footprint

Subdomains3